Cambridge Trust’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-85
Closed -$5.98K 689
2023
Q3
$5.98K Hold
85
﹤0.01% 617
2023
Q2
$6.77K Sell
85
-246
-74% -$17.8K ﹤0.01% 627
2023
Q1
$23.9K Hold
331
﹤0.01% 526
2022
Q4
$27K Buy
331
+85
+35% +$7.01K ﹤0.01% 518
2022
Q3
$19K Hold
246
﹤0.01% 569
2022
Q2
$17K Hold
246
﹤0.01% 624
2022
Q1
$16K Buy
+246
New +$14.3K ﹤0.01% 687

Other funds holding ACHC

Cambridge Trust's ACHC Position: Q4 2023 in Review

Cambridge Trust sold out of Acadia Healthcare (ACHC) in Q4 2023, closing a stake of 85 shares — an estimated $5.98K sold.

Cambridge Trust first reported a position in ACHC in Q1 2022 and held it in 7 quarters. The position peaked at $27K in Q4 2022. 313 funds tracked by Wall St. Rank hold ACHC as of Q4 2023.

  • Cambridge Trust reported no remaining Acadia Healthcare position as of Q4 2023 after selling out during the quarter.
  • Cambridge Trust sold 85 Acadia Healthcare shares in Q4 2023, an estimated $5.98K.
  • Cambridge Trust first reported a position in Acadia Healthcare in Q1 2022 and held it in 7 quarters.
  • Cambridge Trust's Acadia Healthcare position peaked at $27K in Q4 2022.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2023.

Based on Cambridge Trust's 13F filing for Q4 2023, filed 31 Jan 2024.